The global healthcare industry, a cornerstone of human well-being, paradoxically carries a substantial environmental burden, contributing an estimated 4.4% of…
Read More
Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back
Immunai, a pioneering startup dedicated to constructing a comprehensive foundation model of the human immune system, has significantly deepened its…
Read More
Pioneering Immune-Based Therapies: How NK Cell-Derived Extracellular Vesicles Offer New Hope for Traumatic Brain Injury and Alzheimer’s Disease
Traumatic brain injury (TBI) stands as a formidable global health crisis, impacting an estimated 69 million individuals each year with…
Read More
Beyond PD-1: The Drugs Reshaping Cancer Treatment at ASCO 2026
The biotech sector is experiencing a robust resurgence, marked by significant investment, strategic mergers and acquisitions, and groundbreaking clinical advancements,…
Read More
Lilly’s retatrutide shows 28.3% weight loss, but increased side effects
Eli Lilly’s experimental triple hormone receptor agonist, retatrutide, has recently captured significant attention within the medical and pharmaceutical communities following…
Read More
Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma
As Peter Gassner, CEO of Veeva Systems, the long-established cloud software provider dominating the life sciences industry, prepared to take…
Read More
What if psilocybin works about as well for depression as an SSRI?
The burgeoning hope surrounding classic psychedelics as a transformative treatment for depression is beginning to confront the sobering realities of…
Read More
Rubedo Life Sciences’ RLS-1496 Shows Promise in Treating Precancerous Skin Lesions with Minimal Irritation
For millions worldwide grappling with actinic keratoses (AK), the rough, scaly patches of sun-damaged skin that are precursors to squamous…
Read More
CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced a critical initiative to accelerate the development of three investigational vaccines…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potentially life-changing treatments for rare diseases are currently languishing on the shelves of pharmaceutical companies, dormant and…
Read More
